Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oncolytic Virotherapy”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Early research (Phase 1)UnknownNCT05303844
What this trial is testing

Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant Ascites

Who this might be right for
Refractory Malignant Ascites
Fudan University 25
Early research (Phase 1)Looking for participantsNCT07128914
What this trial is testing

A Clinical Study of GO306 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor Malignancies
GeneSail Biotech (Shanghai) Co., Ltd. 32
Early research (Phase 1)Study completedNCT01503177
What this trial is testing

Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Recurrent Malignant MesotheliomaStage IA Malignant MesotheliomaStage IB Malignant Mesothelioma+3 more
Mayo Clinic 15
Testing effectiveness (Phase 2)Study completedNCT01394939
What this trial is testing

Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaCRC
Jennerex Biotherapeutics 52
Large-scale testing (Phase 3)Study completedNCT02562755
What this trial is testing

Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone

Who this might be right for
Hepatocellular Carcinoma (HCC)
SillaJen, Inc. 459
Testing effectiveness (Phase 2)Looking for participantsNCT03866525
What this trial is testing

OH2 Oncolytic Viral Therapy in Solid Tumors

Who this might be right for
Solid TumorGastrointestinal Cancer
Binhui Biopharmaceutical Co., Ltd. 300
Early research (Phase 1)Study completedNCT01584284
What this trial is testing

Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer

Who this might be right for
Cancer of Head and Neck
Genelux Corporation 19
Large-scale testing (Phase 3)Ended earlyNCT02288897
What this trial is testing

PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

Who this might be right for
Cutaneous Melanoma
Provectus Biopharmaceuticals, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT02759588
What this trial is testing

Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer

Who this might be right for
Ovarian CancerPeritoneal CarcinomatosisFallopian Tube Cancer
Genelux Corporation 46
Testing effectiveness (Phase 2)Study completedNCT01199263
What this trial is testing

Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
National Cancer Institute (NCI) 108
Early research (Phase 1)Study completedNCT00562003
What this trial is testing

Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients

Who this might be right for
Ovarian CancerPrimary Peritoneal Cancer
University of Alabama at Birmingham 26
Early research (Phase 1)Looking for participantsNCT05698459
What this trial is testing

OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer

Who this might be right for
Advanced Liver Cancer
Binhui Biopharmaceutical Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT03206073
What this trial is testing

A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Adenocarcinoma+2 more
National Cancer Institute (NCI) 34
Early research (Phase 1)UnknownNCT05675462
What this trial is testing

Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 25
Early research (Phase 1)Study completedNCT04695327
What this trial is testing

TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy

Who this might be right for
Solid Tumor
TILT Biotherapeutics Ltd. 32
Early research (Phase 1)Study completedNCT02457845
What this trial is testing

HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors

Who this might be right for
Supratentorial Neoplasms, MalignantMalignant GliomaGlioblastoma+4 more
Gregory K. Friedman, MD 13
Testing effectiveness (Phase 2)Study completedNCT03004183
What this trial is testing

SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC

Who this might be right for
Metastatic Non-small Cell Lung CancerMetastatic Triple-negative Breast Cancer
The Methodist Hospital Research Institute 57
Early research (Phase 1)Study completedNCT01864759
What this trial is testing

Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma

Who this might be right for
Locally Advanced or Metastatic Melanoma
Institut Català d'Oncologia 14
Testing effectiveness (Phase 2)Ended earlyNCT05248789
What this trial is testing

OH2 Oncolytic Viral Therapy in Advanced Bladder Cancer

Who this might be right for
Advanced Bladder Carcinoma
Binhui Biopharmaceutical Co., Ltd. 4
Early research (Phase 1)Looking for participantsNCT05139056
What this trial is testing

Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas

Who this might be right for
Currently Only Enrolling Glioblastoma Patients at First Recurrence
City of Hope Medical Center 36
Next Page